| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 405 | 12.857 | 34.895 | 39.538 | 38.196 | 51.204 | 64.146 | 80.051 | 78.661 |
| Total Income - EUR | - | 405 | 12.857 | 34.896 | 39.538 | 38.197 | 51.206 | 64.147 | 80.059 | 78.663 |
| Total Expenses - EUR | - | 879 | 7.632 | 15.288 | 15.107 | 13.948 | 14.711 | 18.901 | 36.838 | 40.513 |
| Gross Profit/Loss - EUR | - | -474 | 5.224 | 19.608 | 24.432 | 24.249 | 36.495 | 45.246 | 43.221 | 38.150 |
| Net Profit/Loss - EUR | - | -486 | 4.844 | 18.561 | 23.246 | 23.141 | 34.959 | 43.768 | 42.436 | 35.837 |
| Employees | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dr. Boboc Lavinia Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 6.867 | 5.920 | 4.995 | 4.348 | 11.177 | 8.701 | 5.658 | 19.617 | 12.891 |
| Current Assets | - | 257 | 1.673 | 18.414 | 37.507 | 32.781 | 29.436 | 41.569 | 34.213 | 30.458 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 3.651 | 3.662 | 3.651 | 3.631 |
| Receivables | - | 0 | 1.305 | 12.685 | 22.619 | 10.726 | 14.302 | 17.582 | 21.780 | 16.348 |
| Cash | - | 257 | 369 | 5.729 | 14.888 | 22.055 | 11.483 | 20.324 | 8.782 | 10.479 |
| Shareholders Funds | - | -442 | 4.410 | 22.890 | 35.999 | 43.407 | 36.973 | 45.789 | 44.450 | 37.839 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 7.566 | 3.183 | 519 | 5.855 | 551 | 1.164 | 1.438 | 9.380 | 5.510 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Boboc Lavinia Srl